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This in vivo study employs p27-deficient mice to investigate the significance of p27 for the metabolism of D-type cyclins in differentiated
cells. The absence of p27 results in decreased levels of cyclins D2 and/or D3 in some organs. As demonstrated on Leydig cells of testis, such
dependency is only restricted to certain cell types including terminally differentiated ones, and the absence of p27 in these cells can interfere
with their differentiation. The decrease of cyclin D caused by the absence of p27 equals the amount of cyclin D physically associated with
p27 in non-mutant animals. The data indicate that it is the proportion of p27-associated cyclin D that determines the response to p27
deficiency. Cells in which the level of D-type cyclin is dependent on p27 do not up-regulate the activity of their CDK2 and CDK4 upon loss
of p27, and these cells have a negligible amount of p27 bound to CDK2 and/or cyclin A/E under normal conditions. Together, the findings
suggest the existence of a dual role for p27, one being a classical regulation of cell cycle via inhibition of cyclin-dependent kinases (CDK),
and the other being participation in the establishment and/or maintenance of differentiated status that is realized in conjunction with D-type
cyclins.
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Cyclin-dependent kinases (CDK), their cyclins, and
inhibitors of CDKs (CKI) were identified as the crucial
components of cell cycle-regulating machinery. In mam-
malian cells, the complexes of cyclins D1, D2, D3, A,
and E with relevant CDKs are well understood as motors
that drive cells to enter and to pass through S phase (for
review, see Sherr and Roberts [1] and references therein).
However, surprisingly high levels of D-type cyclins were
also found in various terminally differentiated non-prolif-
erating cells [2–5]. Moreover, differentiation-associated0167-4889/$ - see front matter D 2004 Elsevier B.V. All rights reserved.
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E-mail address: hampl@mendelu.cz (A. Hampl).up-regulation of D-type cyclin(s) is often accompanied
by an increase in levels of CKIs of Cip/Kip family [6–
10], which suggests the importance of such behavior for
establishment and/or maintenance of differentiated pheno-
type. Increased stability of ternary cyclin D–CDK–p27
complexes may then represent the mechanism that allows
for high levels of D-type cyclins to be maintained in
differentiated cells [11]. If this is the case, the levels of
D-type cyclins should be lower in the absence of Cip/Kip
CKIs due to their inability to stably associate with CDK4/
6. Although data that both support and contradict this
prediction exist in literature, no study directly addressing
this phenomenon has been published. For example, mouse
embryonic fibroblasts deficient for p27 and p21 contain
less cyclin D1 and D2 [11], as well as cyclin D3 [12]
than their normal counterparts. Similarly, mammary
glands of p27-deficient mice have a decreased level of
cyclin D1 [13]. In contrast, no alterations in levels of
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mice [14]. While p27-deficient retinas show no changes
in levels of cyclins D1 and D3 [15,16], retinas of cyclin
D1/p27 double null mice have much less cyclin D3 then
retinas of cyclin D1-deficient mice [15]. Also, cyclin D3
is expressed in large amounts in normal Mu¨ller glia, but it
is not detectable in Mu¨ller glia of p27-deficient animals
[17]. Whereas the levels of D-type cyclins in liver and
thymus as well as the assembly of cyclin D–CDK
complexes in heart and kidney in p21/p27 double null
mutant mice are only slightly reduced, the assembly of
cyclin D–CDK complexes in liver and thymus of such
animals is heavily impaired [11].
In this in vivo study, we have employed p27-deficient
mice to further investigate the biological significance of
p27/cyclin D co-regulation by determining the conditions
under which p27 is required for proper levels of individual
D-type cyclins.2. Materials and methods
2.1. Animals and organ lysates
Mice that were deficient in p27 gene [18] were
provided by Dr. James Roberts (Fred Hutchinson Cancer
Research Center, Seattle, WA). They were maintained,
bred, and PCR-genotyped in the animal facility of the
Department of Molecular Embryology, Mendel University,
Brno. Samples of 12 organs of adult (2-month-old) mice
(femoral muscle, heart muscle – right-hand side ventric-
ular region, stomach – fundus wall, kidney cortex, liver,
lung, spleen, testis, ovary, thymus, telencephalon, and
skin from apical part of tail) were lysed on ice in 10
mM Tris–HCl pH 8.0, 25 mM EDTA, 1% SDS, soni-
cated, and cleared by centrifugation at 15000 g for 10
min at 4 jC. After determining the concentrations of total
protein using DC Protein Assay Kit (Bio-Rad, Hercules,
CA), lysates were mixed with double-strength Laemmli
sample buffer, boiled for 5 min and stored at  80 jC
until use.
2.2. Antibodies and reagents
Mouse monoclonal antibody to mouse cyclin D1 (sc-
450); rabbit polyclonal antibodies to mouse cyclin D2 (sc-
593), cyclin A (sc-751), cyclin E (sc-481), p27 (sc-528)
and CDK2 (sc-163), and goat polyclonal antibody to
CDK4 (sc-601-G) were purchased from Santa Cruz Bio-
technology (Santa Cruz, CA). Mouse monoclonal anti-
body to mouse p27 (K25020) was purchased from
Transduction Laboratories (Lexington, KY). Mouse mono-
clonal antibodies against cyclin A (Ab-1, E23) and cyclin
D2 (Ab-4, DCS-3.1 + DCS-5.2) were purchased from
Neomarkers (Fremont, CA). Mouse monoclonal antibody
against a C-terminal part of human cyclin D3, whichcross-reacts with the mouse homologue (DCS-22), was
generously provided by Dr. Jiri Lukas (Danish Cancer
Society, Copenhagen, Denmark). Rabbit polyclonal anti-
body against rat p42/44 MAP kinase, which cross-reacts
with the mouse homologue (#9102), was purchased from
New England Biolabs (Beverly, MA). Horseradish perox-
idase-conjugated anti-immunoglobulins were from Sigma;
polyvinylidene difluoride (PVDF) membrane Hybond-P,
and chemiluminescence detection reagents (ECL + Plus)
were purchased from Amersham (Amersham, Aylesbury,
UK). Equine chorionic gonadotropin (eCG) was from
Bioveta (Ivanovice, Czech Republic). All other chemicals
were purchased from Sigma (St. Louis, MO) or Fluka
(Buchs, Switzerland).
2.3. Western blot analysis
For Western blot analysis, equal amounts of total
protein were subjected to 10% SDS-PAGE, electrotrans-
ferred onto Hybond-P, immunodetected using appropriate
primary and secondary antibodies, and visualized by
ECL + Plus reagent according to the manufacturer’s
instructions. When required, membranes were stripped in
62.5 mM Tris–HCl pH 6.8, 2% SDS, and 100 mM 2-
mercaptoethanol, washed, and reblotted with another an-
tibody from this selection. After immunodetection, each
membrane was stained by amido black to confirm equal
protein loading.
2.4. Immunodepletion, immunoprecipitation, and kinase
assay
For these assays, organ samples (lung, thymus) were
mechanically disintegrated, extracted for 30 min in ice-
cold lysis buffer (50 mM Tris–HCl (pH 7.4), 150 mM
sodium chloride, 0.5% Nonidet P-40, 1 mM EDTA, 0.1
mM dithiothreitol, 50 mM sodium fluoride, 8 mM h-
glycerolphosphate, 100 mM PMSF, 1 Ag/ml leupeptin, 1
Ag/ml aprotinin, 10 Ag/ml soybean trypsin inhibitor, 10
Ag/ml tosylphenylalanine chloromethane). Then extracts
were cleared by centrifugation at 15000 g for 15 min at
4 jC and stored at  80 jC until use. Concentrations of
total protein were determined using a DC Protein Assay
Kit (Bio-Rad). The extracts were first subjected to initial
absorption with Protein G agarose beads and then incu-
bated with appropriate antibodies for 1 h in an ice bath.
Immunoprecipitates were collected on Protein G agarose
beads by overnight rotation, washed five times with lysis
buffer, resuspended in 2 Laemmli sample buffer and
subjected to SDS-PAGE followed by Western blot anal-
ysis. For immunodepletions, aliquots of extracts were
taken before and after the immunoprecipitation procedure
and subjected to Western blot analysis for appropriate
regulator. Each membrane was reblotted with antibody
against p42/44 MAP-kinase in order to confirm an equal
protein content. For kinase assays, immunoprecipitates
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were done using kinase assay buffer (50 mM HEPES, pH
7.5, 10 mM MgCl2, 10 mM MnCl2, 8 mM h-glycerol-
phosphate, 1 mM dithiothreitol). For CDK2, kinase reac-
tions were carried out for 30 min at 37 jC in a total
volume of 25 Al in kinase assay buffer supplemented with
100 Ag/ml histone H1 (type III-S) and 40 ACi/ml [32P]
ATP. For CDK4, kinase reactions were carried out for 30
min at 30 jC in a total volume of 25 Al in kinase assay
buffer supplemented with 80 Ag/ml of GST-pRb and 40
ACi/ml [32P] ATP. Reactions were terminated by mixing
with 2 Laemmli sample buffer, and each total reaction
mix was subjected to SDS-PAGE and autoradiography.
When required, the intensities of signals were assessed by
densitometry using Intelligent Quantifier software (Bio-
Image, Ann Arbor, MI).
2.5. Isolation of Leydig cells and analysis of testosterone
production
Testicular cells of p27-deficient and normal males
were separated into Leydig and non-Leydig populations
in Percoll density gradients essentially as described by
Schumacher et al. [19]. Discontinuous gradient (20%,
37% and 53%) of Percoll was used. Testes from three
to six males were pooled in each sample. The cells in
Leydig cell fraction were counted and the production
of testosterone was assayed using Testosterone kit
(DIAMETRA, Italy) according to manufacturer’s
instructions both with and without hormonal stimulationFig. 1. Expression of D-type cyclins and p27 in selected organs of adult mouse.
stomach, kidney, liver, lung, spleen, ovary, testis, thymus, brain, and skin) of adult
analyzed and representative blots are presented.by eCG. The purity of each Leydig cell fraction was
determined by cytochemical visualization of beta-
hydroxysterol-dehydrogenase as described by Levy et
al. [20]. The data are expressed as the production of
testosterone per 105 Leydig cells by taking into account
the number of all cells in sample and the proportion of
Leydig cells in Leydig cell fraction (this proportion
varied from 65% to 95%). Both Leydig and non-
Leydig cells were also extracted for Western blot
analyses as described above.
2.6. Real-time RT-PC
Total RNA was isolated from tissue using RNeasy Mini
Kit (Qiagen), treated with DNase I, and then re-purified
using RNeasy Mini Kit again (Qiagen). Random primed
cDNAwas synthesized from 1 Ag of total RNA. PCR primer
pairs were as follows: cyclin D1 (5V-AATGCCAGAGGCG-
GATGAGAAC-3V, 5V-AAAGTGCGTTGTGCGGTAGC-
3V); cyclin D2 (5V-TTACCTGGACCGTTTCTTGGC-3V,
5V-CAATGAAGTCGTGAGGGGTGAC-3V); cyclin D3
(5V-CCTACTTCCAGTGCGTGCAAAAG-3V, 5V-
GACAGGTAGCGATCCAGGTAGTTC-3V); GAPDH (5V-
ACCACAGTCCATGCCATCAC-3V, 5V-TCCAC-
CACCCTGTTGCTGTA-3V). Real-time PCR reactions were
carried out by the SYBR-green method (Finnzymes, Fin-
land), using optimized PCR conditions. Each sample was
assayed in triplicate. Thermal cycling was carried out on a
MJ Opticon (MJ Research, Waltham, MA). The results
were analyzed using the Opticon Monitor software (MJThe levels of D-type cyclins and p27 in 12 organs (skeletal muscle, heart,
mice were analyzed by Western blotting. Two females and two males were
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in terms of the threshold cycle (Ct), normalized to GAPDH
(DCt). DCt values were then compared between normal andFig. 2. Levels of D-type cyclins in organs of normal and p27-deficient mice. The
females) of each genotype were analyzed by Western blotting. Expression of p27
proteins to confirm equal protein loading. Since no differences were found betwe
animals for one genotype).p27/ samples to calculate DDCt, (DCt [normal] DCt
[p27/ ]). The final comparison of transcript ratios
between samples was given as 2DDCt.levels of D-type cyclins in organs of four individuals (two males and two
is shown to document the genotype. The membranes were stained for total
en the sexes, only one representative blot is shown for each genotype (two
Fig. 3. Expression of D-type cyclins in Leydig and non-Leydig cells of
testes. Testicular cells of p27-deficient and normal males were separated
into Leydig and non-Leydig populations. Both Leydig and non-Leydig cells
were extracted and Western blotted for all D-type cyclins. Expression of
p27 is shown to document the genotype. Data are representative of at least
three independent replicates.
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3.1. Both D-type cyclins and p27 are broadly expressed in
differentiated tissues
The samples of 12 organs of adult (2-month-old) non-
mutant mice of both sexes were first analyzed by Western
blot for the levels of D-type cyclins and p27 (Fig. 1). Of all
three cyclins, cyclin D1 shows the most restricted expres-
sion, being detectable in five organs, with higher levels in
ovary and thymus. Cyclins D2 and D3 were found in all
organs analyzed except for the absence of cyclins D2 and
D3 in skeletal muscle and cyclin D3 in brain. Similar
widespread expression was seen also for p27 with strikingly
high amounts in lung, spleen, ovary, and thymus.
3.2. Lack of p27 is accompanied by decreased levels of
cyclin D2 and cyclin D3 in some organs
In order to determine to what extent p27 is required for the
maintenance of proper levels of D-type cyclins in vivo, the
same organs as above were obtained from both normal and
p27-deficient mice [18] and Western analyzed for all three
cyclins (Fig. 2). While the levels of cyclin D1 were not
affected by the absence of p27 in any analyzed organ, the
quantities of cyclins D2 and D3 were lowered in some organs
of p27-deficient animals. The extent of this reduction varied
from only slight, such as for cyclin D2 in brain and skin, to a
very large, as exampled by cyclins D2 and D3 in lung.
Notably, in all organs, the occurrence of such cyclin D2/D3
reduction is thoroughly unlinked with the normal level of
p27. For example, (1) cyclin D2 levels decrease in both heart
and ovary despite of the major difference in their normal p27
content, and (2) cyclin D2 remains unchanged in ‘‘high-p27’’
thymus as well as in ‘‘low-p27’’ liver. Moreover, although in
some organs the absence of p27 results in down-regulation of
only cyclin D2 (heart, stomach, brain) or cyclin D3 (spleen),
in others (lung, ovary), the levels of both these D-type cyclins
are lowered.
3.3. Terminally differentiated Leydig cells require p27 to
maintain their D-type cyclin levels at normal
Every organ is composed of various cell types, from
which only some contain p27 and D-type cyclin proteins
as evidenced by immunohistochemical studies [3–5,13,
17,21,22]. Realizing such heterogeneity, it was highly
probable that the overall D-cyclin picture in the partic-
ular p27-deficient organ is determined primarily by the
proportion of cell type(s) with pronounced p27-dependent
regulation of cyclin(s) D. Leydig cells of adult testis
were chosen to verify such a scenario mainly because:
(1) they are fully differentiated and mitotically inactive
[23], (2) they express high levels of both p27 and cyclin
D3 [21], (3) they can be easily isolated and identified,
(4) they represent less then 1% of all testicular cells, and(5) the levels of cyclins D2 and D3 are the same in both
normal and p27-deficient testis (shown in Fig. 2). As
shown in Fig. 3, we found a major difference between
Leydig cells and the remaining cells of testis. While in
non-Leydig cells the absence of p27 had no effect on
the levels of D-type cyclins, in Leydig cells the absence
of p27 brought about the decrease in levels of cyclins
D2 and D3. Thus, although in Leydig cells the levels of
cyclins D2 and D3 are obviously p27-dependent, such
dependency is not observed in testis as a whole due to
the minute number of Leydig cells in this organ.
3.4. Loss of p27 results in deregulated production of
testosterone by Leydig cells
Quantitative data shown in Fig. 3 suggested that co-
regulation between p27 and D-type cyclins may have
some importance for the establishment and/or mainte-
nance of differentiated status. Therefore, we were inter-
ested in whether the differentiation of Leydig cells could
be altered in the absence of p27. Production of testoster-
one, assayed in vitro, was used as a measure of differ-
Fig. 5. Level of mRNA coding for D-type cyclins in lung and thymus. The
total RNA was isolated from lung and thymus and the amounts of mRNA
coding for D-type cyclins were determined by real-time RT-PCR. The results
are presented as a relative change of the amount of mRNA in p27-deficient
mouse compared to normal control. Two sets of independent analyses are
shown (#1 and #2), each with one normal and one p27-deficient animal.
Fig. 4. Production of testosterone by normal and p27-deficient Leydig cells.
Leydig cells were isolated on density gradient and their in vitro testosterone
production was measured by ELISA assay. Testes of 11 normal and of 6
p27-deficient males were analyzed. The data are presented as the
meansF standard deviations. Average age and weight of males, weight of
testis, and the number of testicular cells per male are also given.
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normal and p27-deficient males. As demonstrated in Fig.
4, the levels of testosterone produced by p27-deficient
Leydig cells are almost twice as high as the levels
produced by normal Leydig cells. This difference is
observable in non-stimulated Leydig cells as well as in
Leydig cells stimulated by eCG at concentrations of 7.8
and 31 IU/l. Thus, although p27 is not vital for the
differentiated phenotype of Leydig cells to develop, the
absence of p27 still causes significant abnormalities in
Leydig cell function.
3.5. Down-regulation of D-type cyclin proteins upon the
loss of p27 is not due to the alterations in the levels of their
mRNAs
Lung and thymus, the organs showing ‘‘large’’ versus
‘‘no’’ decrease of cyclins D2/D3 under p27-null condi-
tions (see Fig. 2) were selected for detailed analysisFig. 6. Physical association of D-type cyclins with p27 and CDK4 in lung and thy
extracts were subjected to biochemical analyses. (A) The extracts were and were n
p42/44 MAP-kinase was determined to confirm an equal protein content. To contr
were also included. Densitometry was used to assess the quantity of proteins. For ea
p27+/+ animals was defined as 1.0, and from this value all other values were calcu
bars. (B) The extracts were immunoprecipitated with p27- and CDK4-specific anti
blotting. (C) The extracts were immunoprecipitated with the antibodies specific for
The total amount of D-type cyclins in extracts was analyzed by Western blotting.
four independent replicates.addressing the mechanism(s) by which p27 influences
the levels of D-type cyclins. First, the expression of
mRNAs coding for D-type cyclins was determined using
real-time RT-PCR in normal and p27-deficient organs.
Two sets of independent analyses were carried out (#1
and #2), each using one normal and one p27-deficient
animal. As shown in Fig. 5, the levels of mRNA for all
D-type cyclins were dramatically decreased in thymus of
p27-null animals, whereas only subtle variations were
observed in lung. Obviously, the expression of mRNAs
for D-type cyclins can be influenced by the absence of
p27 protein. Still, neither in lung nor in thymus, themus. Lung and thymus from normal mice were extracted and the resulting
ot immunodepleted of p27 and then analyzed by Western blotting. Level of
ol for a non-specific loss of D-type cyclins, organs from p27 / animals
ch D-type cyclin, the average density of non-immunodepleted samples from
lated. Data represent the means with standard deviations indicated by error
bodies, respectively, and the immunoprecipitates were analyzed by Western
D-type cyclins and then Western blotted with the antibody against p27. (D)
Both immunodepletion and immunoprecipitation data are representative of
V. Bryja et al. / Biochimica et Biophychanges in the levels of cyclin D proteins correspond to
the changes in the levels of their mRNAs. Therefore,
post-transcriptional rather than transcriptional mecha-
nism(s) are likely to underlie the p27/cyclin D co-regula-
tion observed here in lung.3.6. The amount of D-type cyclin missing under p27/
conditions equals its amount normally associated with p27
As it is well-documented on cyclin D3, the cyclin D
pool generally consists of (1) largely inactive cyclin D–
sica Acta 1691 (2004) 105–116 111
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complexes, and of (3) cyclin D that is free of both CDK
and CKI [12]. Therefore, it was possible that the reduc-
tion of levels of cyclin D2 and/or cyclin D3 under p27-
deficient conditions reflected a loss of p27-associated partFig. 7. Kinase activities of CDK2 and CDK4, and physical associations among CD
normal mice were extracted and the resulting extracts were immunoprecipitated us
assayed in vitro for their kinase activities using histone H1 and GST-pRb as substr
cyclin E antibodies, respectively, were probed by Western blotting for associating
CDK4 in extracts was analyzed by Western blotting. The data are representativeof cyclin D pool. If this is the case, an equation that
relates the amount of cyclin D normally associated with
p27 in certain an organ/cell, and the sensitivity of cyclin
D level in such an organ/cell to the absence of p27
should exist. To approach this hypothesis, the extractsK2, cyclin A, cyclin E, and p27 in lung and thymus. Lung and thymus from
ing appropriate antibodies. (A) Immunoprecipitated CDK2 and CDK4 were
ates. (B) Immunoprecipitates made using anti-p27, -CDK2, -cyclin A, and -
p27 and cyclin A. (C) The total amount of cyclin A, cyclin E, CDK2, and
of three independent replicates.
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and then Western blotted for D-type cyclins. As shown in
Fig. 6A, while in lung the quantities of both cyclins D2
and D3 decreased by about 80–90% upon depletion of
p27, this was not the case in thymus. Notably, the
quantity of cyclin D that is refractory to the depletion
by anti-p27 antibody equals the quantity of cyclin D in
p27-deficient animals (P>0.05, Student’s t-test). As dem-
onstrated by immunoprecipitation, cyclins D2 and D3 are
complexed with p27 in both lung and thymus (Fig. 6B,
C). However, while in lung the majority of cyclins D2
and D3 are complexed with p27, only a small portion of
these cyclins associates with p27 in thymus (Fig. 6A). As
documented here on cyclin D3, CDK4 also associates
with p27 and D-type cyclin in both lung and thymus (Fig.
6B), thus potentially connecting p27 to D-type cyclin in
these organs. To ensure the validity of the depletion/
precipitation data, the total amounts of D-type cyclins
were determined by Western blot in all samples used for
such analyses (Fig. 6D).
3.7. Lung and thymus differ from each other in their CDK2-
and CDK4-associated kinase activities and in the amounts
of cyclin A/E–CDK2–p27 complexes
To gain more detailed insight into the differences
between lung and thymus, the activity and composition
of CDK2- and CDK4-containing complexes were also
analyzed. First, CDK2- and CDK4-associated kinase ac-
tivities were determined in lung and thymus from normal
and p27-deficient animals. As we demonstrate in Fig. 7A,
CDK2- and CDK4-associated kinase activities are at
about the same low levels in lung and thymus in the
presence of p27. More importantly, although in thymus
the loss of p27 results in dramatic activation of CDKs, it
has no such effect in lung. Along with this difference in
p27-mediated regulation of the activities of CDKs,
corresponding differences exist in CDK2, cyclin A, and
cyclin E proteins, both in their total amounts and the
amounts physically associated with p27 (Fig. 7B, C). In
general, this data documents that the amounts of total and
p27-bound regulators are at (cyclin E) or below (CDK2,
cyclin A) a limit of detectability in lung but they are
quite high in thymus. We conclude that in cells of thymus
(but not of lung) both cyclin A/E–CDK2 and cyclin D–
CDK4 complexes are active in the absence of p27, and
normally p27 dynamically binds to these complexes in
order to regulate their activity.4. Discussion
Although several previous studies already suggested the
involvement of p27–cyclin D interaction(s) in development
and/or maintenance of the differentiated phenotype [2,4,17,
21,24–26], this study may open a rather new dimension inlooking at such function. Specifically, it documents that: (1)
p27 is necessary for maintaining the proper levels of cyclins
D2 and D3 in vivo; (2) rather then being limited to only few
cell types, this p27-dependency is common to a wide variety
of cells/tissues in a body; (3) defect(s) in differentiation may
develop in the absence of p27 in cells typical by such p27-
dependency; and (4) the reduction of cyclin D amounts
under p27-deficient conditions equals the portion of cyclin
D pool normally associated with p27.
Well-pronounced dependency of D-type cyclins on p27
was found here in many organs. However, there were also
some organs, such as testis, that seemed to lack this type of
co-regulation. Therefore, the hypothesis that even these
organs may still contain cells with p27-dependency was
tested on terminally differentiated Leydig cells of testis. We
demonstrate that in Leydig cells, the levels of cyclins D2
and D3 are in fact p27-dependent. We also show that the
absence of p27 causes Leydig cells to produce about twice
as much testosterone when compared to their normal coun-
terparts. Although unexpected, such functional abnormality
can be explained by p27–cyclin D complexes being in-
volved in the feedback mechanism that negatively regulates
the production of testosterone. Importantly, regardless of the
exact mechanism, p27 (possibly in association with cyclins
D) in Leydig cells seems to serve primarily some purpose
other than regulating G1/S transition, similarly to what has
been summarized by Coqueret [27] for various other cell
types. Combining the data obtained on Leydig cells with
generally high incidence of p27-dependency in the body
leads to the notion that the interaction between p27 and D-
type cyclin described here is employed by differentiating
and/or differentiated cells.
We show here that with the lack p27 CKI, in some
organs the levels of cyclin D proteins are abnormally low,
but this is not due to the down-regulated transcription of
cyclin D genes (see Fig. 5). Instead, the reduction of the
amount of D-type cyclin under p27-deficient conditions
seems to reflect the absence of its pool normally associated
with p27 (see Fig. 6). Concerning the molecular nature of
such interaction between p27 and D-type cyclin, CDK4 is
an obvious candidate for a mediating molecule (both p27
and cyclin D3 physically interact with CDK4 in lung and
thymus; see Fig. 5B). However, although the level of total
cyclin D3 under p27-deficient conditions is appreciably
lowered only in lung and not in thymus, the level of
CDK4-associated cyclin D3 is decreased in both organs. In
other words, cyclin D–CDK4–p27 trimers undergo decay
in both organs and thus may hardly explain the dramatic
difference between lung and thymus in the dependency of
their total cyclins D2 and D3 on the presence of p27.
Therefore, it is highly probable that the p27–cyclin D
interaction observed here in lung (and also in other organs)
employs some molecule(s) other then CDK4.
Irrespective of whether it is CDK4 or some other mole-
cule that mediates the p27–cyclin D interaction in lung, the
ablation of p27 disrupts identical molecular complexes as
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dependence of D-type cyclin(s) on p27 is of some biological
importance, major similarities in phenotypes should exist
between p27/ and cyclin D / animals. In fact, the
findings of Muraoka et al. [13], Fantl et al. [28], and Sicinski
et al. [29], documenting that impaired lobuloalveolar differ-
entiation in the mammary gland and the inability to lactate
develop in both p27-deficient and cyclin D1-deficient ani-
mals, very much fulfill such a prediction. Notably, absence
of p27 in mammary glands is accompanied by a decreased
level of cyclin D1 [13]. Thus, deficiencies of D-type cyclins
and of p27 in mammary glands produce the same phenotype,
most likely due to the requirement of p27 for cyclin D to be
properly metabolized. In Fig. 8 we schematize such a
scenario and offer the concept of a dual role of complexes
involving p27 and D-type cyclins in cell proliferation and
differentiation. In this concept, D-type cyclins associated
with p27 not only contribute to the regulation of proliferation
via their well known link to cyclin A/E–CDK2 activities
(here represented by thymic cells), but they also play some,
although yet elusive, role in establishing and/or maintaining
differentiated status (here represented by Leydig cells and
cells of lung). Importantly, while D-type cyclins and p27 act
primarily in an opposite fashion as regulators of cell prolif-
eration (activation versus inhibition of CDKs), functioningFig. 8. Dual role of D-type cyclins and p27 in proliferation and differentiation—a
from the complexes containing CDK2, and thereby they control their proliferation
yet unidentified, function in differentiation-related processes. Thus, loss of p27 not
cyclin E/A but it may also elicit a decrease in levels of D-type cyclins that results in
titrate p27 from CDK2–cyclin A/E complexes and proliferation becomes suppress
cyclin are reminiscent to the defects produced by the absence of p27.in the same direction seems to be typical for these two
molecules when driving differentiation. Obviously, the most
prominent phenotype in p27-deficient animals is multiorgan
hyperplasia [18,30,31], while cyclin D1-deficient animals
exhibit dwarfism of almost all organs [28,29], both charac-
terizing a loss of proliferation-associated functions of p27
and cyclin D1, respectively. In contrast, the main differen-
tiation-associated alteration in the cyclin D1-deficient
mouse, impaired lobuloalveolar development during preg-
nancy [28,29], is mimicked in p27-deficient mouse [13] as
discussed earlier. At the time of writing this paper, detailed
analysis of the phenotypes of cyclin D1-, cyclin D2-, and
cyclin D3-only mice was published by Ciemerych et al. [32].
Importantly, the concept given in our study allows under-
standing of two molecular abnormalities displayed by such
‘‘single-cyclin’’ mice: (a) level of the remaining, intact D-
type cyclin, is up-regulated; (b) down-regulation of p27
occurring under ‘‘single-cyclin’’ conditions does not produce
increased activity of CDK2. Our concept offers the following
scenario: since normally p27 is complexed with more then
one D-type cyclin, ‘‘single-cyclin D’’ conditions produce
relative overabundance of p27, which is resolved in part by
p27 degradation and shift of p27 to the remaining D-type
cyclin which in turn becomes stabilized and its amount
increases. No changes then occur to the activities of CDKsmodel. Cells employ CDK4/6–cyclin D complexes to flexibly titrate p27
. However, mutual dependency between cyclin D and p27 serves also some,
only causes unrestricted growth due to the inefficient inhibition of CDK2–
differentiation defects. Upon ablation of cyclin D, cells loose their ability to
ed. On the other hand, defects in differentiation caused by the absence of D-
V. Bryja et al. / Biochimica et Biophysica Acta 1691 (2004) 105–116 115simply because non-proliferating/differentiated cells employ
this particular type of interaction between p27 and D-type
cyclins.
Another line of evidence that may also support the
suggested role of D-type cyclins and p27 in cell differentia-
tion comes from the study of Fero et al. [33]. The organs
found in our study as being typical of p27-dependent regu-
lation of D-type cyclins (lung and ovary) are prone to
tumorigenesis in p27-deficient mice [33], whereas the organs
without such regulation only tend to be hyperplastic. Realiz-
ing that tumor formation involves not only the alterations in
proliferation rate but also the changes in differentiation status,
the tumorigenesis in p27-deficient mice can be viewed as a
result of the absence of p27 combined with the reduced levels
of D-type cyclins. In other words, an organ seems to be prone
to p27-mediated tumorigenesis when it employs complexes
containing p27 and D-type cyclin(s) for differentiation status
of its cells to be established and/or maintained.
In conclusion, the results of this study lead us to propose
that dependency of the levels of D-type cyclins on p27 in
fact reflects the role of these cyclins in differentiation-
related processes. Although our data provide clues only on
cyclins D2 and D3, it is still possible that cyclin D1 also
operates in a similar way, and the failure to detect its p27-
dependency is just due to the extremely small proportion of
a particular cell type. Importantly, when the changes in
levels of p27 and/or D-type cyclins occur, they may intro-
duce an alteration in equilibrium between proliferation and
differentiation processes that may finally result in tumor
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